Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlotta Becherini

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Journal of Geriatric Oncology|December 10, 2022
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapyGiulio Francolini, Giulio Frosini, Vanessa Di Cataldo, et al.
Gland Surgery|April 11, 2024
Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 proceduresMarco Bernini, Giacomo Gigliucci, Dario Cassetti, et al.
La Radiologia Medica|January 5, 2019
High-dose intensity-modulated radiation therapy as primary treatment of prostate cancer: genitourinary/gastrointestinal toxicity and outcomes, a single-institution experienceBeatrice Detti, Muhammed Baki, Carlotta Becherini, et al.
The Lancet. Oncology|March 5, 2026
Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapyAntonio Angrisani, Youlia Kirova, Azadeh Abravan, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 22, 2023
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic reviewCarlotta Becherini, Andrea Lancia, Beatrice Detti, et al.
Frontiers in Oncology|September 24, 2024
Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope?Andrea Lancia, Gianluca Ingrosso, Beatrice Detti, et al.
Expert Review of Anticancer Therapy|May 21, 2025
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancerGianluca Ingrosso, Andrea Lancia, Lilia Bardoscia, et al.
American Journal of Clinical Oncology|September 11, 2019
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue SarcomaDaniela Greto, Calogero Saieva, Mauro Loi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2025
Cardiac safety of ultra-hypofractionated whole breast irradiation: Results from the SAFE-FORWARD observational prospective cohort studyViola Salvestrini, Livia Marrazzo, Giuseppe Barletta, et al.
Clinical and Translational Radiation Oncology|September 30, 2022
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)Icro Meattini, Giulio Francolini, Vanessa Di Cataldo, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Journal of Geriatric Oncology|December 10, 2022
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapyGiulio Francolini, Giulio Frosini, Vanessa Di Cataldo, et al.
Gland Surgery|April 11, 2024
Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 proceduresMarco Bernini, Giacomo Gigliucci, Dario Cassetti, et al.
La Radiologia Medica|January 5, 2019
High-dose intensity-modulated radiation therapy as primary treatment of prostate cancer: genitourinary/gastrointestinal toxicity and outcomes, a single-institution experienceBeatrice Detti, Muhammed Baki, Carlotta Becherini, et al.
The Lancet. Oncology|March 5, 2026
Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapyAntonio Angrisani, Youlia Kirova, Azadeh Abravan, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 22, 2023
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic reviewCarlotta Becherini, Andrea Lancia, Beatrice Detti, et al.
Frontiers in Oncology|September 24, 2024
Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope?Andrea Lancia, Gianluca Ingrosso, Beatrice Detti, et al.
Expert Review of Anticancer Therapy|May 21, 2025
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancerGianluca Ingrosso, Andrea Lancia, Lilia Bardoscia, et al.
American Journal of Clinical Oncology|September 11, 2019
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue SarcomaDaniela Greto, Calogero Saieva, Mauro Loi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2025
Cardiac safety of ultra-hypofractionated whole breast irradiation: Results from the SAFE-FORWARD observational prospective cohort studyViola Salvestrini, Livia Marrazzo, Giuseppe Barletta, et al.
Clinical and Translational Radiation Oncology|September 30, 2022
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)Icro Meattini, Giulio Francolini, Vanessa Di Cataldo, et al.
Pageof 8